Please login to the form below

Not currently logged in
Email:
Password:

Emma Walmsley

This page shows the latest Emma Walmsley news and features for those working in and with pharma, biotech and healthcare.

GlaxoSmithKline reportedly looking to sell select antibiotic brands

GlaxoSmithKline reportedly looking to sell select antibiotic brands

On a conference call last month, GSK CEO Emma Walmsley said that the company’s  “first priority remains… to invest in R&D and future growth drivers”. ... Since the beginning of 2019, GSK and new CEO Walmsley have been trying to reverse that deal

Latest news

More from news
Approximately 2 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • Women Leaders in UK Healthcare: Liz Henderson Women Leaders in UK Healthcare: Liz Henderson

    It’s also great to see outside Merck that women are also progressing in other companies too – like Emma Walmsley at GSK – which gives women the inspiration that they too can

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    10. THEODORA HAROLD  . Biotech leader. While big pharma is making some significant strides in having women as their top leaders (most notably GSK’s CEO Emma Walmsley), the biotech sector, particularly

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity to Business Insider UK, ‘‘You cannot be a modern employer in an industry that should be future facing and modernising arguably

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    29. Emma Walmsley, GSK CEO. Emma Walmsley is the first-ever woman leader of a big pharma company, having taken on the CEO role at GlaxoSmithKline in April 2017. ... Since then, Walmsley has very definitely put her own stamp on the firm, making major

  • Pharma deals continue to slide Pharma deals continue to slide

    Emma Walmsley, CEO of GSK, said: “We will use cash for business development purposes, with M&A obviously dependent on the right kind of return profile.”.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics